Cargando…
Cytotoxic effects of docetaxel as a candidate drug of drug-eluting stent on human umbilical vein endothelial cells and the signaling pathway of cell migration inhibition, adhesion delay and shape change
Docetaxel (DTX), a paclitaxel analogue, can efficiently inhibit proliferation of vascular smooth muscle cells and has broadly been used as an antiangiogenesis drug. However, as a candidate drug of drug-eluting stent, the effects of DTX on human umbilical vein endothelial cells (HUVECs) are still not...
Autores principales: | Hu, Tingzhang, Yang, Chun, Fu, Meiling, Yang, Jiali, Du, Rolin, Ran, Xiaolin, Yin, Tieying, Wang, Guixue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458539/ https://www.ncbi.nlm.nih.gov/pubmed/28596914 http://dx.doi.org/10.1093/rb/rbx010 |
Ejemplares similares
-
Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends
por: Tan, Lili, et al.
Publicado: (2022) -
A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
por: Zhao, Yinping, et al.
Publicado: (2020) -
Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019) -
Ureteral stent technology: Drug-eluting stents and stent coatings
por: Yang, Luo, et al.
Publicado: (2015) -
Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
por: Papadopoulos, Kyriacos, et al.
Publicado: (2021)